Skip to main content
WOOREE BIO CO., LTD logo

WOOREE BIO CO., LTD — Investor Relations & Filings

Ticker · 082850 ISIN · KR7082850009 KO Manufacturing
Open in API
Filings indexed 201 across all filing types
Latest filing 2022-04-05 Major Shareholding Noti…
Country KR South Korea
Listing KO 082850

About WOOREE BIO CO., LTD

http://www.wooreebio.co.kr/en/

WOOREE BIO CO., LTD. is a diversified company with two primary business divisions: health functional foods and electronic components. As a specialized OEM/ODM manufacturer, the company produces a range of health functional foods, focusing on the research, development, and sourcing of natural and functional raw materials. It emphasizes open innovation to develop new, individually recognized ingredients. The electronics division manufactures and sells components for the display and lighting industries, including LED package modules and flexible printed circuit boards (FPCBs).

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, volumes, and reasons for changes (e.g., director resignation, share disposal). This falls under the 'Major Shareholding Notification' category.
2022-04-05 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, board member appointments, and other agenda items. This falls directly under the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA), as it reports the official outcomes of shareholder votes at the AGM.
2022-03-30 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the Chief Executive Officer (CEO) of the company '우리바이오' (Woori Bio). It details the outgoing CEO, the incoming CEO, the reason for the change (resignation), and the date of the board resolution. This falls directly under the category of board or management changes.
2022-03-30 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing from Woori Bio regarding a 'Correction of Notice of Convocation of General Meeting of Shareholders'. It details changes to the agenda items for an upcoming Annual General Meeting (AGM), specifically reclassifying the approval of financial statements to a reporting item based on external audit results. Since this document is a formal notice and correction regarding the logistics and agenda of a shareholder meeting, it falls under the category of Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information for meetings.
2022-03-23 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집공고) which includes an amendment (정정신고) to the original notice. It contains the meeting agenda, details on voting procedures, and financial statements (summary balance sheets, income statements, etc.) provided as reference materials for shareholders. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on agenda items at the upcoming meeting.
2022-03-23 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is a correction filing ('정정신고'). It contains detailed financial statements (balance sheets, income statements, cash flow statements) for the company '우리바이오주식회사' as part of the materials provided to shareholders for the upcoming Annual General Meeting. Since this document is a formal proxy solicitation material containing financial disclosures for shareholder voting purposes, it falls under the Proxy Solicitation & Information Statement category.
2022-03-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.